245 related articles for article (PubMed ID: 30113245)
1. A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia.
Viswanathan S; Wah LM
Mult Scler; 2019 Oct; 25(11):1452-1461. PubMed ID: 30113245
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups.
Viswanathan S; Rose N; Arip M; Chai CH; Law WC; Sim R; Ong MC
Mult Scler Relat Disord; 2018 Oct; 25():300-308. PubMed ID: 30172173
[TBL] [Abstract][Full Text] [Related]
3. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence.
Hor JY; Lim TT; Chia YK; Ching YM; Cheah CF; Tan K; Chow HB; Arip M; Eow GB; Easaw PES; Leite MI
Mult Scler Relat Disord; 2018 Jan; 19():20-24. PubMed ID: 29100047
[TBL] [Abstract][Full Text] [Related]
5. NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand.
Bukhari W; Khalilidehkordi E; Mason DF; Barnett MH; Taylor BV; Fabis-Pedrini M; Kermode AG; Subramanian S; Waters P; Broadley SA;
J Neurol; 2022 Feb; 269(2):836-845. PubMed ID: 34213614
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: A prevalence study.
Henríquez K; Molt F; Gajardo J; Cortés B; Ramirez-Santana M
Mult Scler Relat Disord; 2022 May; 61():103750. PubMed ID: 35339742
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
[TBL] [Abstract][Full Text] [Related]
8. Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
Jung SY; Cho EB; Han KD; Jung JH; Yeo Y; Kong SH; Shin DW; Min JH
Osteoporos Int; 2023 May; 34(5):925-933. PubMed ID: 36854747
[TBL] [Abstract][Full Text] [Related]
9. Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina.
Carnero Contentti E; Lopez PA; Pettinicchi JP; Criniti J; Pappolla A; Miguez J; Patrucco L; Cristiano E; Liwacki S; Tkachuk V; Balbuena ME; Vrech C; Deri N; Correale J; Marrodan M; Ysrraelit MC; Leguizamon F; Luetic G; Menichini ML; Tavolini D; Mainella C; Zanga G; Burgos M; Hryb J; Barboza A; Lazaro L; Alonso R; Fernández Liguori N; Nadur D; Chercoff A; Alonso Serena M; Caride A; Paul F; Rojas JI
Mult Scler Relat Disord; 2022 Feb; 58():103466. PubMed ID: 34929456
[TBL] [Abstract][Full Text] [Related]
10. The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.
Liang H; Gao W; Liu X; Liu J; Mao X; Yang M; Long X; Zhou Y; Zhang Q; Zhu J; Wang S; Jin T
J Neuroimmunol; 2019 Dec; 337():577045. PubMed ID: 31520790
[TBL] [Abstract][Full Text] [Related]
11. Internuclear Ophthalmoplegia Characterizes Multiple Sclerosis Rather Than Neuromyelitis Optica Spectrum Disease.
Hamza MM; Alas BF; Huang C; Quon JC; Amezcua L; Robers MV; Gokoffski KK
J Neuroophthalmol; 2022 Jun; 42(2):239-245. PubMed ID: 35427281
[TBL] [Abstract][Full Text] [Related]
12. The risk of type 2 diabetes mellitus in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study.
Cho EB; Han K; Jung JH; Chung YH; Kwon S; Park J; Jin SM; Shin DW; Min JH
Mult Scler Relat Disord; 2024 May; 85():105519. PubMed ID: 38457883
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil.
Lana-Peixoto MA; Talim NC; Pedrosa D; Macedo JM; Santiago-Amaral J
Mult Scler Relat Disord; 2021 May; 50():102807. PubMed ID: 33609926
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prevalence of neuromyelitis optica spectrum disorders in Slovakia.
Szilasiová J; Gazda J; Cimprichová A; Cvengrošová A; Donáth V; Fedičová M; Gurčík L; Hančinová V; Jurčaga F; Kahancová E; Kantorová E; Karlík M; Klímová E; Kováčová S; Krastev G; Megová A; Michalík J; Mikula P; Snopeková Ľ; Števková Z
Neurol Res; 2022 Jan; 44(1):38-46. PubMed ID: 34261427
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity in the multiple sclerosis and neuromyelitis optica spectrum disorders population: findings from an underserved, low income country, Zambia.
Tremlett H; Chomba M; Mortel D; Braun S; Chishimba L; Mutete F; Mwendaweli N; Namangala C; Zimba S; Saylor D
Mult Scler Relat Disord; 2024 Jan; 81():105365. PubMed ID: 38101225
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Rojas JI; Alonso Serena M; Garcea O; Patrucco L; Carrá A; Correale J; Vrech C; Pappolla A; Miguez J; Doldan ML; Silveira F; Alonso R; Cohen L; Pita C; Silva BA; Fiol M; Gaitán MI; Marrodan M; Negrotto L; Ysrraelit MC; Deri N; Luetic G; Caride A; Carnero Contentti E; Lopez PA; Pettinicchi JP; Curbelo C; Martinez AD; Steinberg JD; Balbuena ME; Tkachuk V; Burgos M; Knorre E; Leguizamon F; Piedrabuena R; Liwacki SDV; Barboza AG; Nofal P; Volman G; Alvez Pinheiro A; Hryb J; Tavolini D; Blaya PA; Silva E; Blanche J; Tizio S; Caceres F; Saladino ML; Zanga G; Fracaro ME; Sgrilli G; Pagani Cassara F; Vazquez G; Sinay V; Menichini ML; Lazaro L; Cabrera LM; Bestoso S; Divi P; Jacobo M; Kohler E; Kohler M; Giunta D; Mainella C; Manzi R; Parada Marcilla M; Viglione JP; Martos I; Reich E; Jose G; Cristiano E; Fernández Liguori N;
Neurol Sci; 2020 Jun; 41(6):1513-1519. PubMed ID: 31960250
[TBL] [Abstract][Full Text] [Related]
19. Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea.
Kim H; Park KA; Oh SY; Min JH; Kim BJ
Korean J Ophthalmol; 2019 Feb; 33(1):82-90. PubMed ID: 30746915
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina.
Fernández VC; Alonso N; Melamud L; Villa AM
Mult Scler Relat Disord; 2018 Jan; 19():40-43. PubMed ID: 29125969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
